SATT logo
SATTTargeted Therapy
Status: Active

Investigating Resistance Mechanisms to EGFR TKIs in NSCLC

Study characterizing acquired resistance mechanisms to EGFR tyrosine kinase inhibitors and identifying strategies to overcome resistance.

Institution
Thoracic Oncology Center
Research Area
Molecular Oncology
Year
2025
Status
Active

Medical Disclaimer

The content on this website is for educational and informational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.

Investigating Resistance Mechanisms to EGFR TKIs in NSCLC | SATT